Chile vs Finland: Treatment success rate for patients treated for MDR-TB
Chile
64.0%
in 2022
Finland
63.0%
in 2022
Chile rank
116th
Finland rank
118th
Treatment success rate for patients treated for MDR-TB over time
- Chile
- Finland
How they compare
Chile currently reports 64.0% against 63.0% in Finland, a difference of 1.0%.
The two have swapped places 3 times across 5 shared years of data; in 2015 it was Finland ahead.
Chile ranks 116th and Finland ranks 118th of 163 countries.
Across the 2 decades both report, Chile averaged higher in 1 and Finland in 1.
Head to head by decade
| Decade | Chile | Finland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.5% | 59.2% | 7.8% | Finland |
| 2020s | 64.0% | 63.0% | 1.0% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Chile or Finland?
- Chile, at 64.0% against 63.0% in Finland as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Chile and Finland?
- 1.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Finland?
- 5 years are reported by both, from 2015 to 2022.
- How do Chile and Finland rank globally for treatment success rate for patients treated for mdr-tb?
- Chile ranks 116th and Finland ranks 118th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.